Skip to content
Disclosery

EXANE DERIVATIVES: KMI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on KMI, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 10,938 KMI shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 10,938 shares
    Change vs previous 13F -3,938 shares

    0.11% of the 13F portfolio, value $183,280.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 14,876 shares
    Change vs previous 13F -6,919 shares

    0.08% of the 13F portfolio, value $281,284.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 21,795 shares
    Change vs previous 13F -16 shares

    0.08% of the 13F portfolio, value $345,651.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 21,811 shares
    Change vs previous 13F +4,834 shares

    0.09% of the 13F portfolio, value $364,880.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 16,977 shares
    Change vs previous 13F +12,680 shares

    0.07% of the 13F portfolio, value $310,330.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 4,297 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $71,541.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).